Leonard Bertheau, DO
Family Medicine · Pawtucket, RINPI 1912079500
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $7,000 of the $10,663 with a category attached, or 65.6%. Medtronic accounts for 84.0% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2019 at $8,119 and has fallen 96.1% since, to $319 in 2025. Among family medicine clinicians in RI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 75 payments — averaging $142.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$9K
- Abbott$622
- Dexcom, Inc.$397
- Tandem Diabetes Care, Inc.$285
- Insulet Corporation$156
- Lilly USA, LLC$118
- plus $129 from 3 others
What the payments were for
- Consulting fees$3003%
- Speaking & faculty fees$7,00066%
- Travel & lodging$8918%
- Food & beverage$2,47223%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 35 | $8,957 |
| Abbott | 4 | $622 |
| Dexcom, Inc. | 15 | $397 |
| Tandem Diabetes Care, Inc. | 10 | $285 |
| Insulet Corporation | 1 | $156 |
| Lilly USA, LLC | 3 | $118 |
| Novo Nordisk | 4 | $78 |
| Xeris Pharmaceuticals, Inc. | 2 | $38 |
| BETA Bionics, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Minimed 630G$4,648
- Minimed 670G System$3,107
- FREESTYLE LIBRE 3$302
- Afinion 2$300
- MINIMED 780G$178
- Omnipod$156
- DEXCOM CGM$117
How this compares
$10,663 in reported general payments places this provider in the 95th percentile of 222 family medicine providers in Rhode Island.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 332 | $444,973 |
| TrulicityDulaglutide | 211 | $343,137 |
| MounjaroTirzepatide | 134 | $201,324 |
| OzempicSemaglutide | 131 | $200,191 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 110 | $87,915 |
| Humulin R U-500 KwikpenInsulin Regular, Human | 28 | $62,821 |
| Humalog Kwikpen U-200Insulin Lispro | 13 | $53,755 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 282 | $52,043 |
| Humalog Kwikpen U-100Insulin Lispro | 124 | $51,339 |
| JanuviaSitagliptin Phosphate | 27 | $40,115 |
| Novolog FlexpenInsulin Aspart | 103 | $35,789 |
| FarxigaDapagliflozin Propanediol | 24 | $32,775 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 28 | $25,768 |
| HumalogInsulin Lispro | 50 | $20,693 |
| LantusInsulin Glargine,hum.Rec.Anlog | 98 | $19,761 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity, Mounjaro, Humalog, Humulin N, Humulin 70-30 | $118 | $578,601462 claims |
| Novo NordiskOzempic, Novolog | $78 | $213,250179 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 222 family medicine providers in Rhode Island.
Other family medicine in Pawtucket
- Mary SutterPawtucket$13K
- Caroline RichardsonPawtucket$2K
- Michael DickPawtucket$2K
- Susanna MageePawtucket$1K
- Gina la ProvaCumberland$778K
- Wilfredo Giordano-PerezJohnston$351K
- Martin MinerProvidence$124K
- Frank la FaziaWest Warwick$19K
- Jamiel AmbradWakefield$18K
- Jason AustinJohnston$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.